FIGURE 6.
(A) Network estimates mortality among JAK inhibitors. (B) Rank probabilities among JAK inhibitors for mortality based on the network meta-analysis. (C) Network estimates adverse events among JAK inhibitors. (D) Rank probabilities among JAK inhibitors for adverse events based on the network meta-analysis. CI, confidence interval.
